Skip to main content

Table 1 Primers used in the study

From: Protective paraspeckle hyper-assembly downstream of TDP-43 loss of function in amyotrophic lateral sclerosis

Target

Forward

Reverse

GAPDH

5’-TCGCCAGCCGAGCCA-3′

5’-GAGTTAAAAGCAGCCCTGGTG − 3′

NEAT1 total

5’-CTCACAGGCAGGGGAAATGT-3′

5’-AACACCCACACCCCAAACAA-3′

NEAT1_2

5’-AGAGGCTCAGAGAGGACTGTAACCTG-3′

5′-TGTGTGTGTAAAAGAGAGAAGTTGTGG-3’

TDP-43

5’-TCAGGGCCTTTGCCTTTGTT-3’

5’-TGCTTAGGTTCGGCATTGGAT-3’

IL8

5’-ACACTGCGCCAACACAGAAA-3′

5’-CCTCTGCACCCAGTTTTCCT-3’

ADARB2

ATATTCGTGCGGTTAAAAGAAGGTG

ATCTCGTAGGGAGAGTGGAGTCTTG

Alu RNA

5’-GAGGCTGAGGCAGGAGAATCG-3’

5’-GTCGCCCAGGCTGGAGTG-3’

DICER

5’-TTAACCTTTTGGTGTTTGATGAGTGT-3’

5’-GCGAGGACATGATGGACAATT-3’

DROSHA

5’-CGGCCCGAGAGCCTTTTAT-3’

5’-TGCACACGTCTAACTCTTCCA-3’

ADAR1

5’-TTGTCAACCACCCCAAGGT-3’

5’-CCATCAGCCAGACACCAGTT-3’

AGO2

5’-CACCATGTACTCGGGAGCC-3’

5’-TCCCAAAGTCGGGTCTAGGT-3’

FUS

5’-GCGGGGCTGCTCAGT-3’

5’-TTGGGTTGCTTGTTGGGTAT-3’

CHOP

5’-TTAAAGATGAGCGGGTGGC-3′

5’-GCTTTCAGGTGTGGTGATGTA-3’

CXCL10

5’-TGCCATTCTGATTTGCTGCC-3’

5’-ATGCTGATGCAGGTACAGCG-3’

IFNB1

5’-ACGCCGCATTGACCATCTAT-3’

5’-AGCCAGGAGGTTCTCAACAA-3’

IFNA1

5’-TCTGCTATGACCATGACACGAT-3’

5’-CAGCATGGTCCTCTGTAAGGG-3’

IFNA2

5’-AGGAGGAAGGAATAACATCTGGTC-3’

5’-GCAGGGGTGAGAGTCTTTGAA-3’

MALAT1

5’-GGATCCTAGACCAGCATGCC-3’

5′- AAAGGTTACCATAAGTAAGTTCCAGAAAA-3’

IFIH1

5’-GCATGGAGGAGGAACTGTTGA-3’

5’-GCATGGAGGAGGAACTGTTGA-3’

CYCS

5’-TCGTTGTGCCAGCGACTAAA-3’

5’-GCTTGCCTCCCTTTTCAACG-3’

STAT1

5’-CTGTGCGTAGCTGCTCCTTT-3’

5’-GGTGAACCTGCTCCAGGAAT-3’

MYD88

5’-TGACCCCCTGGGGCAT-3’

5’-AGTTGCCGGATCATCTCCTG-3’

Pri-miR-17–92

5’-CAGTAAAGGTAAGGAGAGCTC

AATCTG-3’

5’-CATACAACCACTAAGCTAAAGAAT

AATCTGA-3’

Pri-miR-15a

5’-CCTTGGAGTAAAGTAGCAGCAC-3’

5’-CCTTGTATTTTTGAGGCAGCAC-3’

miR-18a

5’-CATCATCGGTAAGGTGCATC-3’

5’-GAATCGAGCACCAGTTACGC-3′ (unimiR)

miR-92a

5’-GAGTCTATTGCACTTGTCCC-3’

unimiR

miR-106a

5’-AAAAGTGCTTACAGTGCAGGTAG-3’

unimiR